WithdrawnNot Applicable

Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population

Stopped: The study was withdrawn prior to IRB approval and prior to enrollment. The study was never opened, and no participants were enrolled.

0Started 2015-07

Plain-language summary

The primary objective of this study is to evaluate the efficacy and safety tamsulosin in reducing stent discomfort in the pediatric population in the peri-operative period. The secondary objective is to compare the efficacy of tamsulosin with that of oxybutynin in reducing stent discomfort.

Who can participate

Age range4 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 4-18 years will be enrolled in this study. We will include all patients who will have a ureteral stent placement after their procedure. Exclusion Criteria: * Patients with developmental delay or unable to verbalize their pain level will be excluded.

What they're measuring

Number of doses of pain in medication used

Timeframe: 5 days post-op

Pain scale based on the faces pain score

Timeframe: 5 days post-op

Trial details

NCT IDNCT02483793

SponsorPhoenix Children's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-12

View on ClinicalTrials.gov More Disorder of Urinary Stent trials